<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="3" ids="9334">Sulfasalazine</z:chebi>, a commonly prescribed drug for the treatment of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>, can cause an allergic reaction with <z:e sem="disease" ids="C0235378,C0348754" disease_type="Disease or Syndrome;Injury or Poisoning" abbrv="">hepatotoxicity</z:e>, <z:hpo ids='HP_0002716'>lymphadenopathy</z:hpo>, and <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, many hematologic complications have been observed with <z:chebi fb="3" ids="9334">sulfasalazine</z:chebi>, including <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and <z:hpo ids='HP_0012133'>erythroid hypoplasia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in association with <z:chebi fb="3" ids="9334">sulfasalazine</z:chebi> hypersensitivity has not been previously reported </plain></SENT>
<SENT sid="3" pm="."><plain>We report a child who developed severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:hpo ids='HP_0001903'>anemia</z:hpo> during a hypersensitivity reaction to <z:chebi fb="3" ids="9334">sulfasalazine</z:chebi> </plain></SENT>
</text></document>